hero section gradient
15 handpicked stocks

RegTech Investments (Post-Banking Penalties) Surge

Following a record-breaking $165 million fine levied against ANZ for widespread misconduct, financial institutions are facing immense pressure to bolster their internal controls. This theme focuses on companies poised to benefit as banks accelerate spending on regulatory technology, risk management software, and compliance solutions to avoid similar costly penalties.

Author avatar

Han Tan | Market Analyst

Published on December 19

Your Basket's Financial Footprint

The basket's total market capitalisation is $5.32T and is heavily anchored by large-cap stocks that dominate its weighting. Large-cap dominance generally implies a more stable, market-tracking profile rather than a high-volatility, speculative one.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more market-tracking, suggesting steadier performance and reduced downside risk.
  • Treat as a core holding for diversified portfolios, not a speculative or concentrated growth position.
  • Expect steady, long-term value accumulation rather than rapid, short-term explosive gains.
Total Market Cap
  • FICO: $41.76B

  • NICE: $6.78B

  • RELX: $74.55B

  • Other
โ‰ˆ

About This Group of Stocks

1

Our Expert Thinking

Record-breaking fines like ANZ's ยฃ165 million penalty are creating a compliance crisis across the banking sector. Financial institutions are now compelled to dramatically increase spending on regulatory technology, risk management systems, and compliance infrastructure to avoid similar costly penalties. This represents a significant growth opportunity for companies that provide these essential solutions.

2

What You Need to Know

This group focuses on established technology companies and consultancies that serve the financial services industry with compliance, risk management, and regulatory solutions. These are predominantly large-cap, stable companies that benefit from long-term contracts and increasing regulatory requirements. The theme captures a defensive growth story driven by necessity rather than choice.

3

Why These Stocks

Each company was selected for its proven track record in serving financial institutions with compliance technology, risk management software, or regulatory consulting services. Our analysts identified firms with strong competitive positions in RegTech, established client relationships with major banks, and the technical expertise to help institutions navigate increasingly complex regulatory landscapes.

Why You'll Want to Watch These Stocks

โšก

Compliance Crisis Creates Opportunity

Record fines are forcing banks to spend billions on RegTech solutions. This urgent need for compliance technology creates a powerful tailwind for specialised providers.

๐Ÿ”’

Essential Infrastructure Play

These companies provide mission-critical compliance and risk management systems that banks simply cannot operate without in today's regulatory environment.

๐Ÿ“ˆ

Long-Term Revenue Visibility

Regulatory requirements only get stricter over time, creating predictable, recurring demand for compliance technology and consulting services.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Oracle TikTok Deal May Boost Stocks in 2025

Oracle TikTok Deal May Boost Stocks in 2025

TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.

Pharma Reshoring Explained | Manufacturing Investment

Pharma Reshoring Explained | Manufacturing Investment

Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.

Tesla Ecosystem Players Overview | Chips to Robotics

Tesla Ecosystem Players Overview | Chips to Robotics

Following the Delaware Supreme Court's reinstatement of Elon Musk's massive pay package, investor focus has sharpened on Tesla's ambitious technology roadmap. This theme targets companies poised to gain from the renewed momentum in Tesla's pivot towards AI, robotics, and autonomous systems.

Frequently Asked Questions